by Jessica Casebolt | Jul 17, 2024 | Life Sciences, Tea Leaves
Pfizer has unveiled plans to develop an oral daily medication for weight loss, similar to existing treatments like Ozempic and Zepbound. The pharmaceutical giant reported positive results from clinical trials of its oral GLP-1 agonist candidate danuglipron, indicating...
by Jessica Casebolt | Jul 17, 2024 | M&A, Tea Leaves
The House Appropriations Committee approved the fiscal 2025 HHS spending plan along party lines despite Democratic objections to Republican initiatives aimed at restricting abortion access and restructuring National Institues of Health (NIH). The GOP-proposed budget...
by Jessica Casebolt | Jul 17, 2024 | Providers, Tea Leaves
The Centers for Medicare and Medicaid Services (CMS) has proposed a 2.6 percent reimbursement increase for hospital outpatient departments and ambulatory surgical centers next year, reflecting a projected 3 percent market basket increase offset by a -0.4 percent...
by Jessica Casebolt | Jul 17, 2024 | Payers, Tea Leaves
The Federal Trade Commission (FTC) is poised to sue the three largest pharmacy benefit managers (PBMs) in the United States — CVS’ Caremark, Cigna’s Express Scripts, and UnitedHealth’s Optum Rx — over their pricing negotiations with pharmaceutical...
by Jessica Casebolt | Jul 17, 2024 | M&A, Tea Leaves
Midwest health systems Sanford Health and Marshfield Clinic Health System have announced plans to explore a merger, potentially forming a significant nonprofit entity with 56 hospitals and projected revenues of $10 billion. This merger aims to leverage their...
Recent Comments